Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liv-R Syrup
- Development stage
- Unknown
- Lead developer
- Ritz Pharma
- Administration
- Oral
01
Overview
Liv-R Syrup is an approved Ayurvedic oral liver tonic developed by Ritz Pharma. It is a multi-ingredient formulation containing herbal constituents such as Sharpunkha (Tephrosia purpurea), Bhringra (Eclipta alba), Ghikuwar (Aloe vera), Nausadar (Ammonium chloride), and Chitrak (Plumbago zeylanica). The syrup is indicated for the treatment of acute and chronic viral hepatitis, jaundice, sluggish liver, and hepatotoxicity resulting from food, drugs, or alcohol. It functions as a hepato-corrective and hepatoprotective agent, helping to lower bilirubin levels and protect liver cells from various etiologies of toxicity.
- Brand names
- Liv-R Syrup
- Other names
- Liv-R
Beyond the preview
Go deeper on Liv-R Syrup.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Liv-R Syrup.